Minerva Neurosciences Inc.
NERV | NASDAQ
$3.72
+$0.04 (+1.09%)
Sep 22, 2026, 10:52 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -10.64B | -16.67M | -4.98M | -2.84M | -3.37M | -3.9M | -4.52M | -4.37M | -6.28M | -6.68M | -7.17M | -6.08M | -4.52M | -5.35M | -5.07M | -5.21M | -6.97M | -7.99M | -21.38M | -7.52M | -8.96M | -7.51M |
Interest Income | n/a | 629.6K | 547K | 106.64K | 136.67K | 158.29K | 239.72K | 313.97K | 360.76K | 357.91K | 358.88K | 348.68K | 365.62K | 364.22K | 556.95K | 180.09K | 72.38K | 7.42K | n/a | n/a | n/a | n/a |
Pretax Income | 16.65B | -125.4M | -283.67M | -2.74M | -3.26M | -3.75M | -4.27M | 22.51M | -8.23M | -8.57M | -9.02M | -7.82M | -6.19M | -6.97M | -6.73M | -6.9M | -8.72M | -9.76M | -23.11M | -9.21M | -10.59M | -8.8M |
Net Income | 16.65B | -125.4M | -283.67M | -2.74M | -3.26M | -3.75M | -4.27M | 22.51M | -8.23M | -8.57M | -9.02M | -7.82M | -6.19M | -6.97M | -6.73M | -6.9M | -8.72M | -9.76M | -21.31M | -9.21M | -10.59M | -8.8M |
Selling & General & Admin | 3.45B | 11.42B | 2.81M | 1.92M | 2.08M | 2.54M | 2.54M | 2.48M | 2.42M | 2.51M | 2.45M | 2.64M | 2.63M | 2.69M | 1.88M | 2.84M | 2.83M | 3.03M | 2.63M | 3M | 3.44M | 4.25M |
Research & Development | 7.19B | 5.25B | 2.17M | 925.38K | 1.3M | 1.36M | 1.98M | 1.89M | 3.86M | 4.17M | 4.72M | 3.44M | 1.89M | 2.65M | 3.19M | 2.37M | 4.13M | 4.96M | 18.75M | 4.51M | 5.52M | 3.26M |
Other Expenses | n/a | -16.65B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 10.64B | 16.67M | 4.98M | 2.84M | 3.37M | 3.9M | 4.52M | 4.37M | 6.28M | 6.68M | 7.17M | 6.08M | 4.52M | 5.35M | 5.07M | 5.21M | 6.97M | 7.99M | 21.38M | 7.52M | 8.96M | 7.51M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.31M | 2.25M | 2.19M | 2.08M | 2.03M | 1.98M | 1.93M | 1.88M | 1.83M | 1.78M | 1.73M | 1.69M | 1.61M | 1.3M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 16.67M | 4.98M | 2.84M | 3.37M | 3.9M | 4.52M | 4.37M | 6.28M | 6.68M | 7.17M | 6.08M | 4.52M | 5.35M | 5.07M | 5.21M | 6.97M | 7.99M | 21.38M | 7.52M | 8.96M | 7.51M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.8M | n/a | n/a | n/a |
Shares Outstanding (Basic) | 46.6M | 43.9M | 11.12M | 7.57M | 7.57M | 7.57M | 7.57M | 7.57M | 7.57M | 7.57M | 7.57M | 7.57M | 5.51M | 5.34M | 5.34M | 5.34M | 5.34M | 5.34M | 5.34M | 5.34M | 5.34M | 5.34M |
Shares Outstanding (Diluted) | 79.11M | 43.9M | 11.12M | 7.57M | 7.57M | 7.57M | 7.57M | 7.57M | 7.57M | 7.57M | 7.57M | 7.57M | 5.51M | 5.34M | 5.34M | 5.34M | 5.34M | 5.34M | 5.34M | 5.34M | 5.34M | 5.34M |
EPS (Basic) | 0.36 | -2.86 | -25.51 | -0.36 | -0.43 | -0.50 | -0.56 | 2.97 | -1.09 | -1.13 | -1.19 | -1.03 | -1.12 | -1.31 | -1.26 | -1.61 | -1.62 | -1.83 | -3.99 | -1.72 | -1.98 | -1.65 |
EPS (Diluted) | -0.14 | -2.86 | -25.51 | -0.36 | -0.43 | -0.50 | -0.56 | 2.97 | -1.09 | -1.13 | -1.19 | -1.03 | -1.12 | -1.31 | -1.26 | -1.61 | -1.62 | -1.83 | -3.99 | -1.72 | -1.98 | -1.65 |
EBITDA | -10.64B | -125.4M | -283.67M | -2.74M | -3.26M | -3.75M | -4.27M | 22.52M | -5.91M | -6.31M | -6.82M | -5.73M | -4.15M | -4.99M | -4.79M | -5.02M | -6.89M | -7.99M | -21.38M | -7.5M | -8.93M | -7.47M |
EBIT | n/a | -125.4M | -283.67M | -2.74M | -3.26M | -3.75M | -4.27M | 22.51M | -5.92M | -6.32M | -6.83M | -5.74M | -4.16M | -4.99M | -4.8M | -5.02M | -6.89M | -7.99M | -21.38M | -7.52M | -8.98M | -7.51M |
Depreciation & Amortization | n/a | n/a | 1.36K | 1.36K | 1.36K | 1.36K | 1.36K | 5.62K | 7.75K | 7.75K | 7.75K | 7.75K | 7.75K | 7.75K | 6.39K | 2.13K | n/a | n/a | n/a | 14.94K | 44.01K | 42.83K |
Add to Watchlist
Select watchlists to add or remove NERV